Selective inhibitors of hepatitis C virus replication, Antiviral Research, vol.71, issue.2-3, pp.363-371, 2006. ,
DOI : 10.1016/j.antiviral.2006.06.006
Hepatitis C treatment: an incipient therapeutic revolution, Trends Mol Med, vol.20, pp.315-321, 2014. ,
The price of good health, Nat Med, vol.20, p.24710362, 2014. ,
Hepatitis C Virus and Natural Compounds: A New Antiviral Approach?, Viruses, vol.4, issue.12, pp.2197-2217, 2012. ,
DOI : 10.3390/v4102197
Survey of Anti-HIV and Anti-HCV Compounds from Natural Sources, Can Chem Trans, vol.1, pp.116-140, 2013. ,
ChemInform Abstract: Metabolic Diversity of Lichen-Forming Ascomycetous Fungi: Culturing, Polyketide and Shikimate Metabolite Production, and PKS Genes, ChemInform, vol.25, issue.21, pp.188-200, 2008. ,
DOI : 10.1002/chin.200821269
Lichens???a promising source of bioactive secondary metabolites, Plant Genetic Resources: Characterization and Utilization, vol.55, issue.02, pp.273-287, 2005. ,
DOI : 10.1111/j.1432-1033.2004.03981.x
Biopharmaceutical potential of lichens, Pharmaceutical Biology, vol.197, issue.1, pp.778-798, 2012. ,
DOI : 10.1271/bbb.90419
Phenolic Compounds with In Vitro Activity against Respiratory Syncytial Virus from the Nigerian Lichen Ramalina farinacea, Planta Medica, vol.79, issue.15, pp.1440-1446, 2013. ,
DOI : 10.1055/s-0033-1350711
Identification of Lichen Substances, 1996. ,
Comparative metabolite profiling and chemical study of Ramalina siliquosa complex using LC???ESI-MS/MS approach, Phytochemistry, vol.89, pp.114-124, 2013. ,
DOI : 10.1016/j.phytochem.2013.02.002
URL : https://hal.archives-ouvertes.fr/hal-00865388
??-Orcinol derivatives in lichens: Biogenetic evidence from Oropogon Ioxensis, Experimental Mycology, vol.2, issue.3, pp.245-257, 1978. ,
DOI : 10.1016/S0147-5975(78)80018-8
Lichens, Australian Journal of Chemistry, vol.40, issue.9, pp.1581-1590, 1987. ,
DOI : 10.1071/CH9871581
Robust hepatitis C virus infection in vitro, Proceedings of the National Academy of Sciences, vol.102, issue.26, pp.9294-9299, 2005. ,
DOI : 10.1073/pnas.0503596102
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry, Journal of Virology, vol.80, issue.4, pp.1734-1741, 2006. ,
DOI : 10.1128/JVI.80.4.1734-1741.2006
Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening, The FASEB Journal, vol.23, issue.11, pp.3780-3789, 2009. ,
DOI : 10.1096/fj.09-131920
URL : https://hal.archives-ouvertes.fr/hal-00676358
Complete Replication of Hepatitis C Virus in Cell Culture, Science, vol.309, issue.5734, pp.623-626, 2005. ,
DOI : 10.1126/science.1114016
Inhibitory effects of the lichen metabolite lobaric acid on arachidonate metabolism in vitro, Phytomedicine, vol.2, issue.3, pp.243-246, 1996. ,
DOI : 10.1016/S0944-7113(96)80049-3
Alectosarmentin, a New Antimicrobial Dibenzofuranoid Lactol from the Lichen, Alectoria sarmentosa, Journal of Natural Products, vol.57, issue.7, pp.934-938, 1994. ,
DOI : 10.1021/np50109a009
Carbon-13 NMR Spectroscopic Analysis of 24- MethyI-? 5,22 -Sterols in Rape and Mustard Seed Oils, JAOCS, vol.59, pp.521-523, 1982. ,
Constituents from Thamnolia vermicularis, Acta Bot Yunnanica, vol.24, pp.525-530, 2002. ,
Antioxidant phenolics from Lobaria pulmonaria (L.) Hoffm. and Usnea longissima Ach. lichen species, Turk J Chem, vol.35, pp.647-661, 2011. ,
Chemical constituents from Lobaria isidiophora, Acta Bot Yunnanica, vol.12, pp.447-451, 1990. ,
Chemical constituents of the lichen Stereocaulon azoreum, Z Naturforschung C, vol.47, pp.503-507, 1992. ,
Constituents from Lethariella cladonioides, Fitoterapia, vol.72, issue.7, pp.832-833, 2001. ,
DOI : 10.1016/S0367-326X(01)00287-8
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy, Nature Medicine, vol.31, issue.5, pp.589-595, 2011. ,
DOI : 10.1016/0022-1759(83)90303-4
URL : https://hal.archives-ouvertes.fr/inserm-00705829
Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus, Antiviral Research, vol.83, issue.2, pp.135-142, 2009. ,
DOI : 10.1016/j.antiviral.2009.04.003
Synthesis and antiviral activity of a novel class of (5-oxazolyl)phenyl amines, European Journal of Medicinal Chemistry, vol.69, pp.32-43, 2013. ,
DOI : 10.1016/j.ejmech.2013.07.053
Oxidative stress regulation in lichens and its relevance for survival in coastal habitats, Adv Bot Res, vol.2014, pp.467-503 ,
Antinociceptive Activity of Atranorin in Mice Orofacial Nociception Tests, Zeitschrift f??r Naturforschung C, vol.65, issue.9-10, pp.551-561, 2010. ,
DOI : 10.1515/znc-2010-9-1004
Antimalarial drug interactions of compounds isolated from Kigelia africana (Bignoniaceae) and their synergism with artemether, against the multidrug-resistant W2mef Plasmodium falciparum strain, Parasitology Research, vol.59, issue.3, pp.539-544, 2012. ,
DOI : 10.1007/s00436-011-2519-9
Biologically active components of a Papua New Guinea analgesic and anti-inflammatory lichen preparation, Fitoterapia, vol.80, issue.5, pp.270-273, 2009. ,
DOI : 10.1016/j.fitote.2009.03.003
Biosynthesis by a Non-Redox Mechanism, Journal of Natural Products, vol.62, issue.6, pp.817-820, 1999. ,
DOI : 10.1021/np9803777
Hepatitis C Viral Entry Inhibitors Prolong Viral Suppression by Replication Inhibitors in Persistently-Infected Huh7 Cultures, PLoS ONE, vol.7, issue.6, p.23755208, 2013. ,
DOI : 10.1371/journal.pone.0065273.t005
The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels, Virology, vol.462, issue.463, pp.462-463, 2014. ,
DOI : 10.1016/j.virol.2014.05.024
(???)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry, Hepatology, vol.436, issue.Suppl 1, pp.720-729, 2012. ,
DOI : 10.1002/hep.24803
Structure???activity studies of (???)-epigallocatechin gallate derivatives as HCV entry inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.24, issue.17, pp.4162-4165, 2014. ,
DOI : 10.1016/j.bmcl.2014.07.051
Finding candidate drugs for hepatitis C based on chemicalchemical and chemical-protein interactions, PLoS One, vol.9, p.25225900, 2014. ,
Inhibition of hepatitis C entry: too soon to dismiss while many are still being denied treatment, Gut, vol.349, issue.4, pp.10-1136, 2014. ,
DOI : 10.1136/gutjnl-2014-308396